HCPCS code J0589: DaxibotulinumtoxinA, per 1 unit2026 Medicare rate & RVUs in Guam
This drug code reports daxibotulinumtoxinA-lanm by the administered product-specific unit for treatment such as cervical dystonia.
CMS doesn’t publish an office rate for J0589 in Guam.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J0589 covers
DaxibotulinumtoxinA-lanm is a botulinum toxin type A drug administered by intramuscular injection. It is used in adults for cervical dystonia and for temporary improvement of glabellar lines. Neurologists may administer it for cervical dystonia; dermatologists and other clinicians providing aesthetic treatment may use it for glabellar lines. J0589 identifies the drug and its administered amount, rather than the injection technique or treatment procedure.
CMS assigns J0589 physician fee schedule status E, excluding it from the physician fee schedule. When Medicare covers the drug, it is paid under another payment method; as a Part B drug, it is generally priced using CMS quarterly ASP drug pricing files. Coverage is left to the Medicare contractor’s judgment. Each HCPCS unit represents one unit of daxibotulinumtoxinA-lanm. The units are product-specific and should not be converted to units of another botulinum toxin product.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
J0589 in Hawaii, Guam, HI
| Payment locality | Office | Facility |
|---|---|---|
| Hawaii, Guam, HI | Unavailable | Unavailable |
How the J0589 rate is calculated
Each of J0589’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J0589
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J0589
J0589 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J0589
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J0589 isn’t priced in this setting.
J0589 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J0585OnabotulinumtoxinAPer 1 unit
- Use J0585 for onabotulinumtoxinA. J0589 identifies daxibotulinumtoxinA-lanm; the products have separate, noninterchangeable unit systems.
- J0586AbobotulinumtoxinAPer 5 units
- Use J0586 for abobotulinumtoxinA. J0589 is specific to daxibotulinumtoxinA-lanm, and the products’ units are not interchangeable.
- J0588IncobotulinumtoxinAPer 1 unit
- Use J0588 for incobotulinumtoxinA. J0589 identifies a different type A product, daxibotulinumtoxinA-lanm.
J0589 billing questions
How many milligrams or units does one billing unit represent?
One HCPCS unit represents one unit of daxibotulinumtoxinA-lanm. The code is not reported by milligrams, and its units are not interchangeable with units for other botulinum toxin products.
How is this code different from other botulinum toxin drug codes?
Select J0589 for daxibotulinumtoxinA-lanm. Codes for onabotulinumtoxinA, abobotulinumtoxinA, rimabotulinumtoxinB, or incobotulinumtoxinA identify different products.
How does Medicare price and cover this drug?
J0589 is excluded from the physician fee schedule. When Medicare covers it, the drug is generally paid under the Part B drug method using CMS quarterly ASP pricing files, and coverage is left to the Medicare contractor’s judgment.
What should the record support?
Document the daxibotulinumtoxinA-lanm product, the dose administered, and the clinical reason for treatment.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J0589 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist